Category Archives: Transgender medicine

Did California state prisons perform unethical medical experiments on transgender women in 1987?

Over the past few years, I’ve made a regular habit of seeking out and compiling nearly any published research that’s relevant to trans people and our well-being in society. Often I focus specifically on the medical side of the transgender … Continue reading

Posted in Endocrinology, Ethics, Health care, History, Politics and law, Transgender medicine, Transphobia and prejudice | 2 Comments

Use of puberty blockers in transgender girls, effects on genital tissue development, and vaginoplasty options

  Background and description of the issue GnRH analogue medications such as Lupron, Decapeptyl, and Supprelin LA have been in use since the early 1990s to halt natal pubertal development at Tanner stage 2 or 3 in transgender adolescents with … Continue reading

Posted in Endocrinology, Outcomes of transition, Surgery, Trans youth, Transgender medicine | Leave a comment

Update on case reports: Cyproterone acetate and meningioma in trans women

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Disclaimer: I am not a doctor, and this is not medical advice. Do not take any medication without appropriate medical supervision. Summary Cyproterone acetate (CPA) is commonly used as … Continue reading

Posted in Endocrinology, Oncology, Transgender medicine | Leave a comment

Vocal surgery outcomes in trans women

The field of voice feminization surgery for trans women has been an area of active development in recent years. While testosterone thickens the vocal cords in both cis men and trans men on testosterone, producing a deeper pitch, this is … Continue reading

Posted in Surgery, Transgender medicine | Tagged , | Leave a comment

Additional information on transition treatment for trans women with BRCA1 or BRCA2 mutations

I’ve previously covered existing research on hormone therapy for trans women who are at an increased risk of breast cancer due to BRCA1 or BRCA2 mutations. As transitioning with estrogen induces the growth of breast tissue just as in cis … Continue reading

Posted in Endocrinology, Health care, Oncology, Surgery, Transgender medicine | Tagged , | Leave a comment